#ntprobnp

🔥 Big News for Cardiac IVD Developers! 🔥

GeneMedi proudly offers ready-to-use, fully validated Antigen + Antibody pairs for the two most important cardiac markers:

NT-proBNP antibodies Pair – Your trusted Heart Failure marker ✅ R² > 0.99 correlation with market leaders ✅ Perfect performance on CLIA, ELISA, Lateral Flow ✅ Super-stable & high-affinity

cTnI (Troponin I) antibodies Pair – The Gold Standard for Myocardial Injury ✅ AUC = 0.998 – Exceptional diagnostic accuracy ✅ Zero cross-reactivity with skeletal troponin or cTnT ✅ Outstanding lot-to-lot consistency

Both pairs available NOW as perfectly matched Antigen + Antibody sets from GeneMedi!

🐾 Revolutionize Veterinary Diagnostics with GeneMedi’s NT-proBNP Solutions! 🩺

GeneMedi provides highly validated solutions for detecting cardiac health issues in cats 🐱 and dogs 🐶 with unmatched precision:

🔬 Superior Products: Monoclonal antibody pairs and recombinant antigens for precise detection of cat and dog NT-proBNP.

💡 High Sensitivity & Specificity: Validated for exceptional performance in diagnostic assays.

🌟 Versatile Applications: Optimized for ELISA, CLIA, lateral flow, and POCT, ensuring reliable results across platforms.

✅ Clinically Proven: Validated with diseased and healthy cat and dog serum, achieving 99.9% accuracy compared to ECG.

PATHFAST determines the quantity of NTproBNP and facilitates critical care decisions for patients with congestive heart failure and acute coronary syndrome.

The results from the NTproBNP assay aids in the diagnosis and assessment of severity of congestive heart failure (CHF) and risk stratification in patients with acute coronary syndrome.